| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V42927 | β,β-Trehalose-d14 | 2028292-33-1 | β,β-Trehalose-d14, deuterium labeled β,β-Trehalose |
|
|
V42914 | β,β-Trehalose-d2 | 2028292-30-8 | β,β-Trehalose-d2, deuterium labeled β,β-Trehalose |
|
V49491 | β-Alanine-d4 | 116173-67-2 | β-Alanine-d4 is the deuterium labelled form of β-Alanine. |
|
V43824 | β-Aminopropionitrile HCl | 646-03-7 | β-Aminopropionitrile (BAPN) HCl is a specific, irreversible, orally bioactive aminoacyl oxidase (LOX) inhibitor. |
|
|
V45394 | β-Amyloid, human TFA(human) TFA) | β-Amyloid, human TFA(human) TFA), bioactive compound | |
|
V44457 | β-Amyrone | 638-97-1 | β-Amyrone, triterpene compound |
|
V48157 | β-Caryophyllene-d2 | 2006272-96-2 | β-Caryophyllene-d2 is a deuterium labelled form of β-Caryophyllene. |
|
V47577 | β-catenin-IN-3 | 1005288-15-2 | β-catenin-IN-3 (compound C2) is a potent and specific β-catenin (β-catenin) inhibitor (antagonist) with Kd of 54.96 nM. |
|
V46709 | β-catenin-IN-4 | 2353536-67-9 | β-catenin-IN-4 (Compound 39) is a β-catenin inhibitor (antagonist) with Ki of 0.64 μM. |
|
V48779 | β-Dihydroequilin-d4 | 350819-99-7 | β-Dihydroequilin-d4 is the deuterium labelled form of β-Dihydroequilin. |
|
|
V48610 | β-Dihydroequilin-d5 | β-Dihydroequilin-d5 is the deuterium labelled form of β-Dihydroequilin. | |
|
V50444 | β-Escin | 11072-93-8 | β-Escin, compound of Aesculus hippocastanum L |
|
V50868 | β-Funaltrexamine hydrochloride | 72786-10-8 | β-Funaltrexamine hydrochloride, irreversible MOR antagonist |
|
|
V43516 | β-Glucuronidase-IN-2 | β-Glucuronidase-IN-2 is a potent inhibitor of E. coli β-glucuronidase β-glucuronidase, with IC50 of 0.24 μM and a K< sub>i value of 1.09 μM. | |
|
|
V44096 | β-Glucuronidase/hCAII-IN-1 | β-Glucuronidase/hCAII-IN-2 (Compound 12e) is a potent inhibitor of β-glucuronidase and hCA II with IC50 of 440.1 μM and 4.91 μM, respectively. | |
|
|
V44063 | β-Glucuronidase/hCAII-IN-2 | β-Glucuronidase/hCAII-IN-2 (Compound 12e) is a potent inhibitor of β-glucuronidase and hCA II with IC50 of 670.7 μM and 21.77 μM, respectively. | |
|
V45519 | β-Glucuronide-dPBD-PEG5-NH2 | 2246363-68-6 | β-Glucuronide-dPBD-PEG5-NH2 is a dimer formed by connecting β-glucuronide and pyrrolobenzodiazepine. |
|
V45517 | β-Glucuronide-dPBD-PEG5-NH2 TFA | 2246364-63-4 | β-Glucuronide-dPBD-PEG5-NH2 TFA is a dimer formed by connecting β-glucuronide and pyrrolobenzodiazepine. |
|
V49183 | β-L-Fucopyranosyl phosphate | 16562-59-7 | β-L-Fucopyranosyl phosphate may be utilized in the research/study of glucose metabolism. |
|
V47572 | β-Lactamase-IN-7 | 2419903-21-0 | β-Lactamase-IN-7 is a novel and potent VIM-Type metallo-β-lactamase inhibitorwith Kis of 1.26 μM and 0.54 μM for VIM-1 and VIM-4, respectively. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
